FDA apwouve premye terapi selilè pou trete fòm agresif melanom








Amtagvi se premye terapi selilè pou timè solid ki apwouve pa FDA.


Iovance Biotherapeutics, Inc.


kache caption


aktive caption



Iovance Biotherapeutics, Inc.



Amtagvi se premye...